Skip to main content

Table 1 Patient characteristics (n = 673)

From: Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

Characteristic

N (%)

Age (mean(SD))

63.4 (13.6)

Sex

 Male

375 (55.7)

 Female

298 (44.3)

Ethnicity

 Non-Hispanic white

490 (72.8)

 Non-Hispanic Black

49 (7.3)

 Non-Hispanic Asian Pacific Islander

63 (9.4)

 Hispanic

57 (8.5)

 Other/Unknown

14 (2.1)

Stage at initiation

 Stage III

139 (20.7)

 Stage IV

531 (79.3)

ECOG at initiation

 0

312 (47.9)

  > 1

340 (52.1)

 Months of follow up from initiation (median (range))

18.7 (1.2–77.9)

 Lines of treatment (median(range))

1 (1–7)